Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib cream versus alitretinoin in adults with severe chronic hand eczema
ISRCTN44123892Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in chronic hand dermatitis (CHE) comparing Delgocitinib cream with Alitretinoin capsules (2 arms). Primary endpoint: Change in Hand Eczema Severity Index score. Started Mar 2022; status: completed.
02
Drugs
delgocitinibalitretinoin
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on ISRCTN44123892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44123892.